AVODES

About:

Avodes is a biotechnology company developing treatment and recurrency prevention for Bacterial Vaginosis and Candidiasis.

Website: https://www.avodes.com/

Top Investors: European Commission

Description:

Avodes is a biotechnology company developing treatment and recurrence prevention for Bacterial Vaginosis and Candidiasis. Avodes received Seal of Excellence from EU Accelerator in 2022. Avodes has developed, patented and validated in pilot clinical trials it's first product – „Spomfy” - healthy, moist and biodegradable menstrual sponge.

Total Funding Amount:

450000 EUR

Headquarters Location:

Kaunas, Kauno Apskritis, Lithuania

Founded Date:

2018-01-01

Contact Email:

info(AT)avodes.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-02-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai